Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,424 | -12,896 | -33,536 | -22,751 | -14,217 |
| Depreciation Amortization | 547 | 304 | 289 | 115 | 69 |
| Income taxes - deferred | N/A | N/A | -308 | N/A | N/A |
| Accounts receivable | 68 | -34 | 280 | 29 | 5 |
| Accounts payable and accrued liabilities | -154 | 248 | -130 | 315 | -48 |
| Other Working Capital | 196 | -587 | 900 | -146 | 1,038 |
| Other Operating Activity | 2,037 | 683 | 1,653 | 827 | 576 |
| Operating Cash Flow | $-21,730 | $-12,281 | $-30,851 | $-21,612 | $-12,577 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 52,828 | 20,500 | N/A | N/A | N/A |
| PPE Investments | -280 | -115 | -61 | -48 | -36 |
| Purchase Of Investment | -17,989 | -7,980 | -75,626 | -52,760 | 0 |
| Other Investing Activity | 0 | 0 | 70 | 0 | 0 |
| Investing Cash Flow | $34,559 | $12,405 | $-75,616 | $-52,808 | $-36 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 221 | 193 | 121,600 | 121,593 | 980 |
| Other Financing Activity | 0 | 0 | 22,665 | 22,665 | 24,789 |
| Financing Cash Flow | $221 | $193 | $144,265 | $144,257 | $25,769 |
| Beginning Cash Position | 74,888 | 74,888 | 37,090 | 37,090 | 37,090 |
| End Cash Position | 87,938 | 75,205 | 74,888 | 106,928 | 50,245 |
| Net Cash Flow | $13,049 | $317 | $37,798 | $69,837 | $13,155 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,730 | -12,281 | -30,851 | -21,612 | -12,577 |
| Capital Expenditure | -280 | -115 | -61 | -48 | -36 |
| Free Cash Flow | -22,010 | -12,396 | -30,912 | -21,660 | -12,614 |